Web-based interventions for fear of cancer recurrence: A scoping review with a focus on suggestions for the development and evaluation of future interventions.

Solveiga Zibaite, Sheela Tripathee, Helen Moffat, Beatrix Elsberger, Sara Maclennan
Author Information
  1. Solveiga Zibaite: Department of Psychological Sciences and Health, University of Strathclyde, Glasgow, United Kingdom. ORCID
  2. Sheela Tripathee: Academic Urology Unit, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom.
  3. Helen Moffat: NHS Grampian, Aberdeen Royal Infirmary, Foresterhill Site, Aberdeen, United Kingdom.
  4. Beatrix Elsberger: NHS Grampian, Aberdeen Royal Infirmary, Breast Unit, Aberdeen, United Kingdom. ORCID
  5. Sara Maclennan: Academic Urology Unit, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom.

Abstract

PURPOSE: The objective of this scoping review is to provide an overview of the available evidence on the effectiveness of web-based interventions for fear of cancer recurrence (FCR) and a discussion of drawbacks and possible improvements for web-based interventions identified in the reviewed studies. These steps fulfil the aim of this review, which is to offer suggestions for developing future web-based interventions based on the reviewed studies.
METHODS: Five databases (PubMed, MEDLINE, EMBASE, SCOPUS and Web of Science) were searched. Original peer-reviewed articles, written in English, on web-based interventions for FCR were included for review. The data from the included studies was synthesised thematically.
RESULTS: We included 34 papers reporting on 28 interventions. Most of the studies in the papers were quantitative and mixed quantitative studies with a qualitative element, e.g. an interview post-intervention. Interventions were most commonly trialled with women breast cancer patients. Top three countries where studies were conducted were USA, Australia and the Netherlands. The most common theoretical framework for interventions is cognitive behavioural therapy (CBT), followed by mindfulness-based and mixed CBT, mindfulness, acceptance and commitment therapy (ACT), relaxation approaches. FCR was the primary focus/measure in 19 Studies, in 9 studies FCR was a secondary/related outcome/measure. Overall, the evidence of efficacy of web-based interventions on FCR is mixed.
CONCLUSIONS: The existing research suggests several key points for producing more robust evidence about the effectiveness of web-based interventions for FCR. First, the studies suggest that it is a priority to better define eligibility criteria to proactively include people with higher levels of FCR. Second, there is a need for longer-term follow-up and outcome measuring period. Third, research examining the reasons for dropout from web-based interventions for FCR is critical to improve the effectiveness of web-based interventions. Fourth, while web-based interventions do not involve the costs of transportation, traveling time, space, equipment, cleaning, and other expenses, further cost utility analyses should be performed. Finally, future studies should assess how intervention accessibility, adherence, and effectiveness can be improved across different intervention designs, varying from intensive synchronous individual therapist-assisted web-based programme to blended designs combining the advantages of face-to-face and internet-based elements, to entirely self-managed programmes.
IMPLICATIONS FOR CANCER SURVIVORS: Developing and evaluating more accessible FCR treatments have been identified among top international FCR research priorities (Shaw et al. 2021). While there is some evidence that web-based interventions can be as effective as face-to-face interventions, currently there is a dearth of systematic data about the ways in which the web-based modality specifically can enhance supportive care for FCR. Developing knowledge about effective web-based interventions has implications for cancer survivors as they can be presented with more accessible, low-cost and low-burden options for managing fear of cancer recurrence.

References

  1. J Med Internet Res. 2020 May 19;22(5):e17824 [PMID: 32209529]
  2. JMIR Res Protoc. 2020 May 11;9(5):e15178 [PMID: 32390591]
  3. Support Care Cancer. 2016 Aug;24(8):3265-8 [PMID: 27169703]
  4. Jpn J Clin Oncol. 2023 Nov 5;53(11):1068-1076 [PMID: 37567587]
  5. Front Psychol. 2021 Feb 22;12:596682 [PMID: 33692719]
  6. Psychooncology. 2022 Jun;31(6):879-892 [PMID: 35388525]
  7. Psychooncology. 2018 Nov;27(11):2546-2558 [PMID: 29744965]
  8. J Med Internet Res. 2020 Oct 2;22(10):e17526 [PMID: 33006567]
  9. J Clin Oncol. 2015 Sep 1;33(25):2763-71 [PMID: 26169621]
  10. J Med Internet Res. 2010 Nov 18;12(4):e52 [PMID: 21087922]
  11. Ann Behav Med. 2023 Aug 21;57(9):787-799 [PMID: 37078920]
  12. Breast. 2022 Apr;62:123-134 [PMID: 35176683]
  13. Cancer Treat Rev. 2019 Mar;74:1-14 [PMID: 30658289]
  14. BMC Cancer. 2019 May 16;19(1):462 [PMID: 31096934]
  15. Front Psychol. 2021 Dec 10;12:811602 [PMID: 34956033]
  16. Complement Ther Clin Pract. 2022 Nov;49:101686 [PMID: 36347151]
  17. Health Qual Life Outcomes. 2018 Feb 9;16(1):30 [PMID: 29471823]
  18. Jpn J Clin Oncol. 2019 Jun 1;49(6):537-544 [PMID: 30793156]
  19. Cancer. 2021 Feb 1;127(3):334-338 [PMID: 33048350]
  20. Int J Behav Med. 2016 Dec;23(6):776-794 [PMID: 26957109]
  21. Diabetes Metab Syndr. 2020 Sep - Oct;14(5):943-946 [PMID: 32599533]
  22. J Clin Oncol. 2018 Aug 10;36(23):2413-2421 [PMID: 29953304]
  23. Front Psychol. 2021 Feb 25;12:634136 [PMID: 33716902]
  24. Cancer. 2017 Apr 15;123(8):1424-1433 [PMID: 28055119]
  25. JMIR Cancer. 2021 Jan 13;7(1):e16785 [PMID: 33439132]
  26. J Adv Nurs. 2022 Oct;78(10):3069-3082 [PMID: 35696315]
  27. J Natl Cancer Inst. 2021 Nov 2;113(11):1495-1505 [PMID: 34057469]
  28. Curr Opin Support Palliat Care. 2020 Mar;14(1):40-50 [PMID: 31789944]
  29. J Cancer Surviv. 2020 Oct;14(5):601-606 [PMID: 32335850]
  30. Cancer Nurs. 2023 Aug 8;: [PMID: 37552227]
  31. Psychooncology. 2023 Sep;32(9):1348-1358 [PMID: 37571918]
  32. J Clin Oncol. 2019 Nov 1;37(31):2899-2915 [PMID: 31532725]
  33. J Clin Oncol. 2023 Feb 10;41(5):1069-1078 [PMID: 36322882]
  34. Cancer. 2024 Aug 15;130(16):2739-2742 [PMID: 38630904]
  35. Psychooncology. 2020 Feb;29(2):430-436 [PMID: 31713279]
  36. Psychooncology. 2023 Sep;32(9):1424-1432 [PMID: 37489745]
  37. Psychooncology. 2020 Jan;29(1):98-106 [PMID: 31483911]
  38. J Telemed Telecare. 2024 Apr;30(3):405-419 [PMID: 35108131]
  39. Breast. 2018 Aug;40:181-188 [PMID: 29906741]
  40. Qual Health Res. 2012 Oct;22(10):1435-43 [PMID: 22829486]
  41. BMC Cancer. 2018 Jul 18;18(1):748 [PMID: 30021555]
  42. J Clin Oncol. 2017 Jul 1;35(19):2173-2183 [PMID: 28471726]
  43. Int J Environ Res Public Health. 2023 Oct 17;20(20): [PMID: 37887671]
  44. J Clin Med. 2020 Sep 14;9(9): [PMID: 32937942]
  45. Eur J Cancer Care (Engl). 2017 Nov;26(6): [PMID: 28544085]
  46. Psychooncology. 2022 Aug;31(8):1381-1389 [PMID: 35470502]
  47. Patient Educ Couns. 2020 Mar;103(3):549-555 [PMID: 31558323]
  48. J Cancer Surviv. 2013 Sep;7(3):300-22 [PMID: 23475398]
  49. J Med Internet Res. 2019 Oct 18;21(10):e14065 [PMID: 31628791]
  50. Psychooncology. 2022 Feb;31(2):338-341 [PMID: 34519384]
  51. Internet Interv. 2017 Jun 15;9:57-64 [PMID: 30135838]
  52. J Cancer Surviv. 2023 Aug;17(4):1017-1035 [PMID: 36307611]
  53. Psychooncology. 2020 Sep;29(9):1380-1383 [PMID: 32497353]
  54. Support Care Cancer. 2022 Sep;30(9):7323-7332 [PMID: 35606479]
  55. Patient Educ Couns. 2015 Mar;98(3):283-95 [PMID: 25535016]
  56. Cyberpsychol Behav Soc Netw. 2014 Sep;17(9):624-9 [PMID: 25167082]
  57. Am Psychol. 2021 Jan;76(1):14-25 [PMID: 32816503]
  58. Psychooncology. 2023 Dec;32(12):1839-1847 [PMID: 37850876]
  59. Psychol Health. 2021 Nov;36(11):1352-1367 [PMID: 33251861]
  60. Health Psychol. 2016 Dec;35(12):1320-1328 [PMID: 27513475]
  61. BMJ Open. 2022 Jan 12;12(1):e057212 [PMID: 35022179]
  62. Psychooncology. 2020 Jan;29(1):76-85 [PMID: 31659822]
  63. Psychooncology. 2018 Feb;27(2):524-531 [PMID: 28665541]
  64. J Cancer Surviv. 2024 Apr;18(2):425-438 [PMID: 35876964]
  65. Support Care Cancer. 2019 Jul;27(7):2735-2746 [PMID: 30506103]
  66. J Clin Oncol. 2017 Dec 20;35(36):4066-4077 [PMID: 29095681]
  67. JMIR Cancer. 2022 Jan 11;8(1):e29745 [PMID: 35014956]
  68. Psychooncology. 2020 Jan;29(1):86-97 [PMID: 31595627]
  69. J Med Internet Res. 2020 Nov 16;22(11):e20709 [PMID: 33196452]
  70. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-10 [PMID: 35561298]

MeSH Term

Humans
Fear
Neoplasm Recurrence, Local
Internet-Based Intervention
Cognitive Behavioral Therapy
Female
Internet
Mindfulness

Word Cloud

Created with Highcharts 10.0.0interventionsweb-basedFCRstudiescancerreviewevidenceeffectivenesscanfearfutureincludedmixedresearchscopingrecurrenceidentifiedreviewedsuggestionsdatapapersquantitativetherapyCBTinterventiondesignsface-to-faceDevelopingaccessibleeffectivePURPOSE:objectiveprovideoverviewavailablediscussiondrawbackspossibleimprovementsstepsfulfilaimofferdevelopingbasedMETHODS:FivedatabasesPubMedMEDLINEEMBASESCOPUSWebSciencesearchedOriginalpeer-reviewedarticleswrittenEnglishsynthesisedthematicallyRESULTS:34reporting28qualitativeelementeginterviewpost-interventionInterventionscommonlytrialledwomenbreastpatientsTopthreecountriesconductedUSAAustraliaNetherlandscommontheoreticalframeworkcognitivebehaviouralfollowedmindfulness-basedmindfulnessacceptancecommitmentACTrelaxationapproachesprimaryfocus/measure19Studies9secondary/relatedoutcome/measureOverallefficacyCONCLUSIONS:existingsuggestsseveralkeypointsproducingrobustFirstsuggestprioritybetterdefineeligibilitycriteriaproactivelyincludepeoplehigherlevelsSecondneedlonger-termfollow-upoutcomemeasuringperiodThirdexaminingreasonsdropoutcriticalimproveFourthinvolvecoststransportationtravelingtimespaceequipmentcleaningexpensescostutilityanalysesperformedFinallyassessaccessibilityadherenceimprovedacrossdifferentvaryingintensivesynchronousindividualtherapist-assistedprogrammeblendedcombiningadvantagesinternet-basedelementsentirelyself-managedprogrammesIMPLICATIONSFORCANCERSURVIVORS:evaluatingtreatmentsamongtopinternationalprioritiesShawetal2021currentlydearthsystematicwaysmodalityspecificallyenhancesupportivecareknowledgeimplicationssurvivorspresentedlow-costlow-burdenoptionsmanagingWeb-basedrecurrence:focusdevelopmentevaluation

Similar Articles

Cited By